Biggest News Aggregation in the World
📰 Dish Network News

Page 59 - Dish Network News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Dish Network. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Kineta Reports Positive Safety, Pharmacokinetic Data For KVA12123 From Ongoing Phase 1/2 Trial

Kineta, Inc. (KA) announced an update on its ongoing Phase 1/2 clinical trial evaluating KVA12123 in patients with advanced solid tumors. KVA12123 cleared the first three monotherapy dose levels and was well tolerated with no dose limiting toxicities or cytokine related adverse events observed.
United States Ohio Metal Center Network Corp Communications Commission Indiana Metal Center Enforcement Bureau

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science